HK262
HK262 is a METTL21A inhibitor, with an IC50 of 1.10 μM against human METTL21A. HK262 reduces the enzymatic activity of the protein lysine methyltransferase METTL21A. HK262 can be used in studies of hepatocellular carcinoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C16H15F5N6O4S
- 分子量:482.39
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
Histone Methyltransferase アイソフォーム固有の製品をすべて表示
More
生物活性
製品説明
IC50 & Target
[1]|
METTL21A 1.10 μM (IC50) |
体外実験
HK262 (compound 6n) is the most potent METTL21A inhibitor identified in this series, with an IC50 of 1.10 μM for the purified recombinant human METTL21A enzyme[1].
HK262 (100 μM; 2 h) displays favorable kinetic solubility of 85 μM in pH 7.4 phosphate-buffered saline[1].
HK262 (120 min) exhibits high stability in both human and mouse plasma following 120 min of incubation[1].
HK262 (45 min) displays high metabolic stability in vitro in both human liver microsomes and mouse liver microsomes after 45 min of incubation[1].
HK262 (50 μM; 60 min) achieves high intracellular accumulation of 1824 μM in HepG2 cells following 60 min of exposure to an initial 50 μM extracellular concentration[1].
HK262 (10 μM; 72 h) does not reduce the viability of HepG2 cells after 72 h of exposure at 10 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2 cells
-
Concentration:10 μM
-
Incubation Time:72 h
-
Result:Resulted in HepG2 cell viability of 102% of the untreated control value after 72 h of exposure, with no observable reduction in cell viability.
化学情報
-
分子量 482.39
-
分子式 C16H15F5N6O4S
-
SMILES
O[C@H]1[C@@H](O)[C@H](N2C=NC3=C(N)N=CN=C23)O[C@@H]1C(NC4=CC=C(S(F)(F)(F)(F)F)C=C4)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)